The coming of age of drug-susceptibility testing for tuberculosis. Cox, H. & Mizrahi, V. New England Journal of Medicine, Massachusetts Medical Society, sep, 2018.
The coming of age of drug-susceptibility testing for tuberculosis [link]Paper  doi  abstract   bibtex   
Tuberculosis is the leading infectious cause of death worldwide, claiming 1.6 million lives annually.1 Antimicrobial resistance is undermining efforts to curb the global tuberculosis epidemic: among the 10.6 million cases of tuberculosis that occurred in 2016, less than a quarter of the estimated 600,000 patients with multidrug-resistant (MDR) or rifampin-resistant tuberculosis received diagnoses and were treated. Although rollout of the Xpert MTB/RIF molecular test has enabled the rapid detection of resistance to the first-line tuberculosis drug rifampin, a diagnostic test that can accurately determine the complete drug-susceptibility profile of the infecting strain or strains of Mycobacterium tuberculosis would make it . . .
@article{Cox2018,
abstract = {Tuberculosis is the leading infectious cause of death worldwide, claiming 1.6 million lives annually.1 Antimicrobial resistance is undermining efforts to curb the global tuberculosis epidemic: among the 10.6 million cases of tuberculosis that occurred in 2016, less than a quarter of the estimated 600,000 patients with multidrug-resistant (MDR) or rifampin-resistant tuberculosis received diagnoses and were treated. Although rollout of the Xpert MTB/RIF molecular test has enabled the rapid detection of resistance to the first-line tuberculosis drug rifampin, a diagnostic test that can accurately determine the complete drug-susceptibility profile of the infecting strain or strains of Mycobacterium tuberculosis would make it . . .},
author = {Cox, Helen and Mizrahi, Valerie},
doi = {10.1056/NEJMe1811861},
journal = {New England Journal of Medicine},
keywords = {editorial,fund{\_}not{\_}ack},
mendeley-tags = {editorial,fund{\_}not{\_}ack},
month = {sep},
pages = {NEJMe1811861},
pmid = {30256713},
publisher = {Massachusetts Medical Society},
title = {{The coming of age of drug-susceptibility testing for tuberculosis}},
url = {http://www.nejm.org/doi/10.1056/NEJMe1811861},
year = {2018}
}

Downloads: 0